Replies to post #116 on Sol Global Investments Corp. (SOLCF)

[PotterBanker]

Scythian Biosciences Announces Major Milestone in U.S. Expansion

https://globenewswire.com/news-release/2018/10/11/1619914/0/en/Scythian-Biosciences-Announces-Major-Milestone-in-U-S-Expansion.html

October 11, 2018 08:15 ET | Source: Scythian Biosciences Corp.

Florida Department of Health Approves CannCure’s Purchase of 60% of the Equity of 3 Boys Farms Including the License to Operate as a Medical Marijuana Treatment Center in Florida

3 Boys Farms Gets Former Incredibles Edibles Master Grower Chris Keller as its Master Grower

Chris, Formerly with Incredibles, One of the Industry’s Leading Vape, Extracts and Wellness Companies, Has Nearly Two Decades of Experience in Greenhouse Architecture, Management and Cultivation. Under Chris’s Cultivation Expertise, Incredibles Became the Most Nationally Awarded, Cannabis Infused Product Company

TORONTO, Oct. 11, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) today announced the Florida Department of Health, Office of Medical Marijuana Use (“DOH”) has approved the transfer of 60% of the Equity of 3 Boys Farms, LLC. (“3 Boys Farms”) to CannCure Investments Inc. (“CannCure”) including 3 Boys Farms’ license to operate as a Medical Marijuana Treatment Center in Florida. As part of the transaction, the DOH has also approved the initial transfer of the first 60% of equity from 3 Boys Farms to CannCure and the remaining balance of 40% will close as soon as possible, subject to the receipt of all required governmental approvals from the DOH.

“This is a major milestone in the rollout of our U.S. expansion,” said Scythian CEO Brady Cobb. “It’s an important part of the strong presence we are building in the burgeoning U.S. cannabis industry, with Florida representing one of the most coveted markets to be a licensed operator in.”

[PotterBanker]

Scythian Biosciences Applauds the UK Government’s Decision to Legalize Medical Cannabis

https://globenewswire.com/news-release/2018/10/12/1620519/0/en/Scythian-Biosciences-Applauds-the-UK-Government-s-Decision-to-Legalize-Medical-Cannabis.html

October 12, 2018 08:15 ET | Source: Scythian Biosciences Corp.

Scythian’s Chief Medical Officer, The Famed Dr. Barnes, Receives National Praise for His Advocacy, Education and Tireless Leadership from Government, Media and Medical Organizations to Assist in Making This Major Event Happen

TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) applauds the United Kingdom’s decision to allow specialist doctors the option to legally issue prescriptions for cannabis-based medicines when they believe patients could benefit from the treatment. Specialist doctors in England, Wales and Scotland will be able to prescribe cannabis-derived medicines in less than a month.

The law change, passed in Parliament yesterday, came after Home Secretary Sajid Javid listened to concerns from parents of children with conditions such as severe epilepsy. Over the summer an urgent review of cannabis-based medicinal products was called following an outcry over two young epilepsy sufferers, Alfie Dingley and Billy Caldwell, being denied access to cannabis oil.

“Congratulations to the UK Government and Home Secretary Sajid Javid, and a special congratulations to our own Chief Medical Officer, Michael Barnes, whose years of work, collaborative efforts with members of government and insatiable dedication to legalizing medicinal cannabis use helped make this decision occur,” said CEO Brady Cobb. “Scythian is proud to have you as a senior leader of our team and strongly supports your ongoing initiatives.”